Objective: Human menopausal gonadotropin (HMG) is one of the commonest drugs used for ovarian stimulation with no reports on the audio-vestibular system. This study aims to examine HMG on the hearing profile of patients planning intracytoplasmic sperm injection (ICSI).
Methods: This prospective study was conducted from June 2016 to June 2017 in a tertiary referral hospital.